Monogram Biosciences Announces First Quarter 2009 Financial Results Conference Call

* Reuters is not responsible for the content in this press release.

Wed Apr 29, 2009 6:30pm EDT 

SOUTH SAN FRANCISCO, Calif.--(Business Wire)--
Monogram Biosciences, Inc., (Nasdaq:MGRM) announced that it will hold a
conference call on Wednesday, May 6, 2009 at 4:30 p.m. (Eastern Time) to discuss
first quarter 2009 financial results. The call will be hosted by Mr. William D.
Young, Chairman and CEO of Monogram. 

To participate in the live teleconference, please call (877) 545-1407, or (719)
325-4847 for international callers, fifteen minutes before the conference
begins. Live audio of the call will be simultaneously broadcast over the
Internet and will be available to members of the news media, investors and the
general public. Following the live broadcast, a replay of the call will also be
available beginning at 9:30 p.m. (Eastern Time) at (888) 203-1112, or (719)
457-0820 for international callers, until 11:59 p.m. (Eastern Time) on Sunday,
May 17, 2009. The replay passcode is 8727141. Access to live and archived audio
of the conference call will be available by following the appropriate links at
www.monogrambio.com and clicking on the Investor Relations link. 

The information provided on the teleconference is only accurate at the time of
the conference call, and Monogram will take no responsibility for providing
updated information except as required by law. 

About Monogram Biosciences, Inc.

Monogram is advancing individualized medicine by discovering, developing and
marketing innovative products to guide and improve treatment of serious
infectious diseases and cancer. The Company's products are designed to help
doctors optimize treatment regimens for their patients that lead to better
outcomes and reduced costs. The Company's technology is also being used by
numerous biopharmaceutical companies to develop new and improved antiviral
therapeutics and vaccines as well as targeted cancer therapeutics. More
information about the Company and its technology can be found on its web site at
www.monogrambio.com. 





Monogram Biosciences, Inc.
Alfred G. Merriweather, 650-624-4576
Chief Financial Officer
amerriweather@monogrambio.com
or
Feinstein Kean Healthcare
Jeremiah Hall, 415-677-2700
jeremiah.hall@fkhealth.com



Copyright Business Wire 2009
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.